|
US7219016B2
(en)
|
2001-04-20 |
2007-05-15 |
Yale University |
Systems and methods for automated analysis of cells and tissues
|
|
EP1392359B2
(en)
|
2001-05-11 |
2013-03-13 |
Ludwig Institute for Cancer Research Ltd. |
Specific binding proteins and uses thereof
|
|
US20100056762A1
(en)
|
2001-05-11 |
2010-03-04 |
Old Lloyd J |
Specific binding proteins and uses thereof
|
|
ES2741546T3
(es)
*
|
2004-03-31 |
2020-02-11 |
Massachusetts Gen Hospital |
Método para determinar la respuesta del cáncer a tratamientos dirigidos al receptor del factor de crecimiento epidérmico
|
|
EP3042964A1
(en)
*
|
2004-06-04 |
2016-07-13 |
Genentech, Inc. |
Egfr mutations
|
|
TW200617396A
(en)
*
|
2004-10-06 |
2006-06-01 |
Astrazeneca Ab |
Method
|
|
BRPI0517105B1
(pt)
*
|
2004-10-18 |
2015-06-23 |
Univ Brandeis |
Método para análise de pelo menos um produto de amplificação fita simples de um processo de amplificação de ácido nucléico não-simétrico
|
|
WO2006070667A1
(ja)
*
|
2004-12-28 |
2006-07-06 |
Takara Bio Inc. |
Ｅｇｆｒ遺伝子変異の検出法ならびに検出キット
|
|
DE602006021142D1
(de)
*
|
2005-02-03 |
2011-05-19 |
Gen Hospital Corp |
Verfahren zur behandlung von gefitinib-resistentem krebs
|
|
CA2597673C
(en)
|
2005-02-11 |
2014-07-08 |
Harold Varmus |
Methods and compositions for detecting a drug resistant egfr mutant
|
|
US7981605B2
(en)
|
2005-02-24 |
2011-07-19 |
Amgen Inc. |
Epidermal growth factor receptor mutations
|
|
GB0506670D0
(en)
*
|
2005-04-01 |
2005-05-11 |
Astrazeneca Ab |
Method
|
|
GB2424886A
(en)
*
|
2005-04-04 |
2006-10-11 |
Dxs Ltd |
Polynucleotide primers against epidermal growth factor receptor and method of detecting gene mutations
|
|
WO2006108087A2
(en)
|
2005-04-05 |
2006-10-12 |
Cellpoint Diagnostics |
Devices and methods for enrichment and alteration of circulating tumor cells and other particles
|
|
BRPI0610574A2
(pt)
*
|
2005-04-14 |
2010-07-06 |
Wyeth Corp |
uso de um inibidor de quinase para receptor do fator de crescimento epidérmico (egfr) em pacientes resistentes a gefitinib
|
|
JP2008546421A
(ja)
*
|
2005-06-28 |
2008-12-25 |
ジェネンテック・インコーポレーテッド |
Ｅｇｆｒおよびｋｒａｓ変異
|
|
JP2009511008A
(ja)
*
|
2005-10-05 |
2009-03-19 |
アストラゼネカ ユーケー リミテッド |
ＥｒｂＢ受容体薬に対する患者の応答を予測またはモニタリングする方法
|
|
PE20070763A1
(es)
|
2005-11-04 |
2007-08-08 |
Wyeth Corp |
COMBINACIONES ANTINEOPLASICAS DE UN INHIBIDOR DE mTOR, TRASTUZUMAB Y/O HKI-272
|
|
EP2340837B1
(en)
*
|
2005-11-11 |
2017-03-15 |
Boehringer Ingelheim International GmbH |
Combination treatment of cancer comprising egfr/her2 inhibitors
|
|
CA2629244C
(en)
|
2005-11-11 |
2014-08-05 |
Boehringer Ingelheim International Gmbh |
Quinazoline derivatives for the treatment of cancer diseases
|
|
EP1988164A4
(en)
*
|
2006-02-23 |
2009-04-22 |
Univ Kanazawa Nat Univ Corp |
METHOD FOR TESTING THE SENSITIVITY OF A SOLID TUMOR AGAINST TYROSINE KINASE INHIBITOR AND TEST KIT THEREFOR
|
|
US7736905B2
(en)
*
|
2006-03-31 |
2010-06-15 |
Biodesix, Inc. |
Method and system for determining whether a drug will be effective on a patient with a disease
|
|
US7867775B2
(en)
*
|
2006-03-31 |
2011-01-11 |
Biodesix, Inc. |
Selection of head and neck cancer patients for treatment with drugs targeting EGFR pathway
|
|
US7906342B2
(en)
|
2006-03-31 |
2011-03-15 |
Biodesix, Inc. |
Monitoring treatment of cancer patients with drugs targeting EGFR pathway using mass spectrometry of patient samples
|
|
CA2650776A1
(en)
|
2006-05-05 |
2007-11-15 |
Yale University |
Immunohistochemical methods for determining signal transduction activity in tumors
|
|
US12366585B2
(en)
|
2006-05-18 |
2025-07-22 |
Caris Mpi, Inc. |
Molecular profiling of tumors
|
|
BRPI0711011A2
(pt)
*
|
2006-05-18 |
2011-08-23 |
Molecular Profiling Institute, Inc. |
método para a determinação da intervenção médica para um estado de doença, método para a identificação de uma terapia de droga com capacidade de interação com um alvo molecular e sistema para a determinação da intervenção médica individualizada para um estado de doença
|
|
US8768629B2
(en)
*
|
2009-02-11 |
2014-07-01 |
Caris Mpi, Inc. |
Molecular profiling of tumors
|
|
CN108048549B
(zh)
|
2006-06-14 |
2021-10-26 |
维里纳塔健康公司 |
使用样品拆分和dna标签进行稀有细胞分析
|
|
EP2589668A1
(en)
|
2006-06-14 |
2013-05-08 |
Verinata Health, Inc |
Rare cell analysis using sample splitting and DNA tags
|
|
CA2657324A1
(en)
*
|
2006-07-13 |
2008-01-17 |
Yale University |
Methods for making cancer prognoses based on subcellular localization of biomarkers
|
|
PT2068880E
(pt)
*
|
2006-09-18 |
2012-07-12 |
Boehringer Ingelheim Int |
Método para tratamento do cancro apresentando mutações no egfr
|
|
US8283625B2
(en)
*
|
2006-09-28 |
2012-10-09 |
Shimadzu Corporation |
Method of preparing sample for matrix-assisted laser desorption ionization mass spectrometry and matrix-assisted laser desorption ionization mass spectrometry
|
|
JP4795203B2
(ja)
*
|
2006-11-13 |
2011-10-19 |
シスメックス株式会社 |
アンスラサイクリン系抗癌剤の感受性判定方法及びそのシステム
|
|
US9090693B2
(en)
|
2007-01-25 |
2015-07-28 |
Dana-Farber Cancer Institute |
Use of anti-EGFR antibodies in treatment of EGFR mutant mediated disease
|
|
DK2129396T3
(da)
|
2007-02-16 |
2013-11-25 |
Merrimack Pharmaceuticals Inc |
Antistoffer mod ErbB3 og anvendelser deraf
|
|
PE20090690A1
(es)
*
|
2007-03-13 |
2009-06-22 |
Amgen Inc |
Mutaciones de k-ras y b-raf y terapia con anticuerpos anti-egfr
|
|
RS53265B2
(sr)
|
2007-03-13 |
2022-06-30 |
Amgen Inc |
K-ras mutacije i terapija anti-egfr antitelom
|
|
CN101688229B
(zh)
|
2007-03-15 |
2013-06-12 |
路德维格癌症研究所 |
包含egfr抗体和src抑制剂的组合物及其在制备用于治疗哺乳动物癌症的药物中的用途
|
|
US8642067B2
(en)
|
2007-04-02 |
2014-02-04 |
Allergen, Inc. |
Methods and compositions for intraocular administration to treat ocular conditions
|
|
US8999634B2
(en)
|
2007-04-27 |
2015-04-07 |
Quest Diagnostics Investments Incorporated |
Nucleic acid detection combining amplification with fragmentation
|
|
MX2009012271A
(es)
*
|
2007-05-11 |
2010-02-04 |
Enzon Pharmaceuticals Inc |
Compuestos antagonistas de acido ribonucleico para la modulacion de her3.
|
|
US20090155767A1
(en)
*
|
2007-06-29 |
2009-06-18 |
Rimm David L |
Methods for a predictive diagnostic test for tamoxifen
|
|
CN101896503B
(zh)
|
2007-08-14 |
2018-05-22 |
路德维格癌症研究所有限公司 |
靶向egf受体的单克隆抗体175及其衍生物和用途
|
|
US8022216B2
(en)
|
2007-10-17 |
2011-09-20 |
Wyeth Llc |
Maleate salts of (E)-N-{4-[3-chloro-4-(2-pyridinylmethoxy)anilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(dimethylamino)-2-butenamide and crystalline forms thereof
|
|
KR20100127768A
(ko)
|
2008-02-01 |
2010-12-06 |
더 제너럴 하스피탈 코포레이션 |
의학적 질환 및 병태의 진단, 예후, 및 치료에 있어서 미세소포체의 용도
|
|
SI2271767T1
(sl)
*
|
2008-04-03 |
2016-12-30 |
Cb Biotechnologies, Inc. |
Osvoboditev amplikona multipla verižna reakcija s polimerazo za pomnoževanje multiplih tarč
|
|
US8137919B2
(en)
*
|
2008-04-10 |
2012-03-20 |
Montefiore Medical Center |
Method of determining the sensitivity of cancer cells to EGFR inhibitors including cetuximab, panitumumab and erlotinib
|
|
CN101445829B
(zh)
*
|
2008-04-23 |
2013-06-05 |
广州益善生物技术有限公司 |
Egfr基因突变位点的检测探针、液相芯片及其检测方法
|
|
ES2692769T3
(es)
|
2008-06-17 |
2018-12-05 |
Wyeth Llc |
Combinaciones antineoplásicas que contienen HKI-272 y vinorelbina
|
|
CN109464445A
(zh)
|
2008-08-04 |
2019-03-15 |
惠氏有限责任公司 |
4-苯胺基-3-氰基喹啉和卡培他滨的抗肿瘤组合
|
|
CA2732658A1
(en)
*
|
2008-08-15 |
2010-02-18 |
Merrimack Pharmaceuticals, Inc. |
Methods and systems for predicting response of cells to a therapeutic agent
|
|
US8583380B2
(en)
|
2008-09-05 |
2013-11-12 |
Aueon, Inc. |
Methods for stratifying and annotating cancer drug treatment options
|
|
US12162008B2
(en)
|
2008-09-23 |
2024-12-10 |
Bio-Rad Laboratories, Inc. |
Partition-based method of analysis
|
|
US9417190B2
(en)
|
2008-09-23 |
2016-08-16 |
Bio-Rad Laboratories, Inc. |
Calibrations and controls for droplet-based assays
|
|
US9132394B2
(en)
|
2008-09-23 |
2015-09-15 |
Bio-Rad Laboratories, Inc. |
System for detection of spaced droplets
|
|
US12090480B2
(en)
|
2008-09-23 |
2024-09-17 |
Bio-Rad Laboratories, Inc. |
Partition-based method of analysis
|
|
US9492797B2
(en)
|
2008-09-23 |
2016-11-15 |
Bio-Rad Laboratories, Inc. |
System for detection of spaced droplets
|
|
US10512910B2
(en)
|
2008-09-23 |
2019-12-24 |
Bio-Rad Laboratories, Inc. |
Droplet-based analysis method
|
|
US8709762B2
(en)
|
2010-03-02 |
2014-04-29 |
Bio-Rad Laboratories, Inc. |
System for hot-start amplification via a multiple emulsion
|
|
GB2477053B
(en)
|
2008-09-23 |
2013-11-13 |
Quantalife Inc |
Droplet-based assay system
|
|
US8951939B2
(en)
|
2011-07-12 |
2015-02-10 |
Bio-Rad Laboratories, Inc. |
Digital assays with multiplexed detection of two or more targets in the same optical channel
|
|
US9156010B2
(en)
|
2008-09-23 |
2015-10-13 |
Bio-Rad Laboratories, Inc. |
Droplet-based assay system
|
|
US9764322B2
(en)
|
2008-09-23 |
2017-09-19 |
Bio-Rad Laboratories, Inc. |
System for generating droplets with pressure monitoring
|
|
US9399215B2
(en)
|
2012-04-13 |
2016-07-26 |
Bio-Rad Laboratories, Inc. |
Sample holder with a well having a wicking promoter
|
|
US9194861B2
(en)
|
2009-09-02 |
2015-11-24 |
Bio-Rad Laboratories, Inc. |
Method of mixing fluids by coalescence of multiple emulsions
|
|
US11130128B2
(en)
|
2008-09-23 |
2021-09-28 |
Bio-Rad Laboratories, Inc. |
Detection method for a target nucleic acid
|
|
US8633015B2
(en)
|
2008-09-23 |
2014-01-21 |
Bio-Rad Laboratories, Inc. |
Flow-based thermocycling system with thermoelectric cooler
|
|
WO2011120020A1
(en)
|
2010-03-25 |
2011-09-29 |
Quantalife, Inc. |
Droplet transport system for detection
|
|
EP3075864A1
(en)
*
|
2008-10-14 |
2016-10-05 |
Caris MPI, Inc. |
Gene and gene expressed protein targets depicting biomarker patterns and signature sets by tumor type
|
|
EP3722810A3
(en)
*
|
2009-02-11 |
2021-01-13 |
Caris MPI, Inc. |
Molecular profiling of tumors
|
|
US20110320392A1
(en)
*
|
2009-03-02 |
2011-12-29 |
Black Esther P |
Methods for predicting cancer response to egfr inhibitors
|
|
LT3000467T
(lt)
|
2009-04-06 |
2023-04-11 |
Wyeth Llc |
Krūties vėžio gydymo schema naudojant neratinibą
|
|
WO2011003853A2
(en)
|
2009-07-06 |
2011-01-13 |
Boehringer Ingelheim International Gmbh |
Process for drying of bibw2992, of its salts and of solid pharmaceutical formulations comprising this active ingredient
|
|
US20130029339A1
(en)
|
2009-09-09 |
2013-01-31 |
The General Hospital Corporation |
Use of microvesicles in analyzing kras mutations
|
|
EP2475790A4
(en)
*
|
2009-09-10 |
2013-03-20 |
Myriad Genetics Inc |
METHOD AND COMPOSITION FOR PREDICTING THE REACTION TO CANCER THERAPY
|
|
US8323883B1
(en)
|
2009-10-09 |
2012-12-04 |
Cold Spring Harbor Laboratory |
Methods of assessing therapeutic benefits of patients having cancers resistant to epidermal growth factor receptor kinase inhibitors
|
|
US7947653B1
(en)
|
2009-10-09 |
2011-05-24 |
Cold Spring Harbor Laboratory |
Methods for treating epidermal growth factor receptor tyrosine kinase inhibitor-resistant cancers
|
|
WO2011056741A2
(en)
|
2009-11-09 |
2011-05-12 |
Wyeth Llc |
Coated drug spheroids and uses thereof for eliminating or reducing conditions such as emesis and diarrhea
|
|
JP2013510564A
(ja)
|
2009-11-13 |
2013-03-28 |
パンガエア ビオテック、ソシエダッド、リミターダ |
肺癌におけるチロシンキナーゼ阻害剤に対する応答を予測するための分子バイオマーカー
|
|
US9034658B2
(en)
|
2009-11-23 |
2015-05-19 |
The General Hospital Corporation |
Microfluidic devices for the capture of biological sample components
|
|
WO2011072258A1
(en)
*
|
2009-12-11 |
2011-06-16 |
Catholic Healthcare West |
Pi3k/akt pathway subgroups in cancer: methods of using biomarkers for diagnosis and therapy
|
|
US10731221B2
(en)
|
2009-12-11 |
2020-08-04 |
Dignity Health |
Diagnosing IDH1 related subgroups and treatment of cancer
|
|
TWI405566B
(zh)
*
|
2010-02-11 |
2013-08-21 |
Univ Nat Taiwan |
薑黃素或其類似物於使用上皮細胞生長因子接受器酪胺酸激酶抑制劑之癌症醫療之用途
|
|
US8399198B2
(en)
|
2010-03-02 |
2013-03-19 |
Bio-Rad Laboratories, Inc. |
Assays with droplets transformed into capsules
|
|
NZ602084A
(en)
|
2010-03-11 |
2014-07-25 |
Merrimack Pharmaceuticals Inc |
Use of erbb3 inhibitors in the treatment of triple negative and basal-like breast cancers
|
|
WO2011113942A2
(en)
*
|
2010-03-18 |
2011-09-22 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Method for predicting the responsiveness to chemotherapy
|
|
EP2550351A4
(en)
|
2010-03-25 |
2014-07-09 |
Quantalife Inc |
DETECTION SYSTEM FOR DROPLET-BASED ANALYZES
|
|
EP2550528B1
(en)
|
2010-03-25 |
2019-09-11 |
Bio-Rad Laboratories, Inc. |
Droplet generation for droplet-based assays
|
|
CN102234683B
(zh)
*
|
2010-04-23 |
2013-07-17 |
广州益善生物技术有限公司 |
一种egfr基因突变检测液相芯片
|
|
CN101858909B
(zh)
*
|
2010-05-28 |
2013-07-03 |
广州瑞博奥生物科技有限公司 |
检测磷酸化表皮生长因子受体的试剂盒及其制备方法
|
|
IN2013MN00522A
(cg-RX-API-DMAC7.html)
|
2010-09-24 |
2015-05-29 |
Univ Leland Stanford Junior |
|
|
WO2012043633A1
(ja)
*
|
2010-09-30 |
2012-04-05 |
独立行政法人国立精神・神経医療研究センター |
優性変異遺伝子発現抑制剤
|
|
EA201390575A1
(ru)
|
2010-10-29 |
2014-01-30 |
Иммьюноджен, Инк. |
Неантагонистические egfr-связывающие молекулы и их иммуноконъюгаты
|
|
MX2013004761A
(es)
|
2010-10-29 |
2013-08-27 |
Immunogen Inc |
Nuevas moleculas de union al receptor del factor de crecimiento epidermico (egfr) e inmunoconjugados de estas.
|
|
EP3132844B1
(en)
|
2010-11-01 |
2019-08-28 |
Bio-Rad Laboratories, Inc. |
System for forming emulsions
|
|
WO2012065071A2
(en)
*
|
2010-11-12 |
2012-05-18 |
The Broad Institute Of Mit And Harvard |
Methods of predicting response to egfr antibody therapy
|
|
WO2012065705A1
(en)
|
2010-11-19 |
2012-05-24 |
Roche Diagnostics Gmbh |
Novel complex mutation in the epidermal growth factor receptor kinase domain
|
|
US20120164641A1
(en)
|
2010-12-22 |
2012-06-28 |
Roche Molecular Systems, Inc. |
Methods and Compositions for Detecting Mutation in the Human Epidermal Growth Factor Receptor Gene
|
|
CN102140518B
(zh)
*
|
2011-01-18 |
2013-02-06 |
杭州迪安医学检验中心有限公司 |
肺癌相关表皮生长因子受体egfr外显子突变定量检测试剂盒及方法
|
|
WO2012103442A2
(en)
|
2011-01-28 |
2012-08-02 |
The Broad Institute, Inc. |
Paired end bead amplification and high throughput sequencing
|
|
EP2668504A4
(en)
|
2011-01-28 |
2015-06-10 |
Biodesix Inc |
PREDICTIVE TEST FOR SELECTING PATIENTS WITH METASTATIC BREAST CANCERS TO RECEIVE HORMONE THERAPY AND POLY THERAPY
|
|
US9556473B2
(en)
|
2011-02-15 |
2017-01-31 |
Leica Biosystems Newcastle Ltd |
Methods for identifying nucleic acid sequences
|
|
CN113151404A
(zh)
|
2011-02-15 |
2021-07-23 |
莱卡生物系统纽卡斯尔有限责任公司 |
用于mrna的定位的原位检测的方法
|
|
US12097495B2
(en)
|
2011-02-18 |
2024-09-24 |
Bio-Rad Laboratories, Inc. |
Methods and compositions for detecting genetic material
|
|
EP2492688A1
(en)
|
2011-02-23 |
2012-08-29 |
Pangaea Biotech, S.A. |
Molecular biomarkers for predicting response to antitumor treatment in lung cancer
|
|
WO2012129145A1
(en)
|
2011-03-18 |
2012-09-27 |
OSI Pharmaceuticals, LLC |
Nscle combination therapy
|
|
EP2686449B1
(en)
|
2011-03-18 |
2020-11-18 |
Bio-Rad Laboratories, Inc. |
Multiplexed digital assays with combinatorial use of signals
|
|
EP3789498B1
(en)
|
2011-04-25 |
2025-08-13 |
Bio-Rad Laboratories, Inc. |
Methods for nucleic acid analysis
|
|
JP5930825B2
(ja)
*
|
2011-05-06 |
2016-06-08 |
アークレイ株式会社 |
Ｅｇｆｒエクソン１９多型検出試験用試薬キット及びその用途
|
|
WO2013019751A1
(en)
|
2011-07-29 |
2013-02-07 |
Bio-Rad Laboratories, Inc., |
Library characterization by digital assay
|
|
US9174216B2
(en)
|
2013-03-13 |
2015-11-03 |
DeNovo Science, Inc. |
System for capturing and analyzing cells
|
|
US10466160B2
(en)
|
2011-08-01 |
2019-11-05 |
Celsee Diagnostics, Inc. |
System and method for retrieving and analyzing particles
|
|
US9404864B2
(en)
|
2013-03-13 |
2016-08-02 |
Denovo Sciences, Inc. |
System for imaging captured cells
|
|
CA2842359A1
(en)
|
2011-08-01 |
2013-02-07 |
Denovo Sciences |
Cell capture system and method of use
|
|
WO2013022961A1
(en)
|
2011-08-08 |
2013-02-14 |
3The Broad Institute |
Compositions and methods for co-amplifying subsequences of a nucleic acid fragment sequence
|
|
US9738935B2
(en)
*
|
2011-11-10 |
2017-08-22 |
Roche Molecular Systems, Inc. |
Complex mutations in the epidermal growth factor receptor kinase domain
|
|
MX2014006087A
(es)
*
|
2011-11-21 |
2014-08-01 |
Immunogen Inc |
Metodo de tratamiento de tumores que son resistentes a terapias contra el receptor del factor de crecimiento epidermico (egfr) con agentes citotoxicos conjugados con anticuerpos dirigidos contra el receptor del factor de crecimiento epidermico.
|
|
US9260714B2
(en)
|
2011-12-02 |
2016-02-16 |
Roche Molecular Systems, Inc. |
Suppression of non-specific amplification with high-homology oligonucleotides
|
|
KR101963230B1
(ko)
|
2011-12-26 |
2019-03-29 |
삼성전자주식회사 |
복수개의 단일 항체를 포함하는 단백질 복합체
|
|
EP2653558B1
(en)
|
2012-04-18 |
2015-10-07 |
Roche Diagniostics GmbH |
A method of detecting nucleic acid targets using a statistical classifier
|
|
CN102732636B
(zh)
*
|
2012-07-17 |
2014-01-15 |
海南医学院 |
一种检测肿瘤细胞egfr基因突变的芯片
|
|
CN102851375B
(zh)
*
|
2012-09-11 |
2014-02-19 |
上海源奇生物医药科技有限公司 |
检测egfr基因突变的引物、探针及其试剂盒和使用方法
|
|
KR101911438B1
(ko)
*
|
2012-10-31 |
2018-10-24 |
삼성전자주식회사 |
이중 특이 항원 결합 단백질 복합체 및 이중 특이 항체의 제조 방법
|
|
US20140341884A1
(en)
*
|
2012-12-04 |
2014-11-20 |
Roche Molecular Systems, Inc. |
Novel Complex Mutations in the Epidermal Growth Factor Receptor Kinase Domain
|
|
US9752181B2
(en)
|
2013-01-26 |
2017-09-05 |
Denovo Sciences, Inc. |
System and method for capturing and analyzing cells
|
|
SI2964638T1
(sl)
|
2013-03-06 |
2017-11-30 |
Astrazeneca Ab |
Kinazolinski inhibitorji aktiviranja mutantnih oblik receptorja epidermalnega rastnega faktorja
|
|
US20140287417A1
(en)
|
2013-03-08 |
2014-09-25 |
Roche Molecular Systems, Inc. |
EGFR Blood Monitoring
|
|
CA2902099C
(en)
|
2013-03-08 |
2020-06-02 |
F. Hoffmann-La Roche Ag |
Egfr mutation blood testing
|
|
US9707562B2
(en)
|
2013-03-13 |
2017-07-18 |
Denovo Sciences, Inc. |
System for capturing and analyzing cells
|
|
US10391490B2
(en)
|
2013-05-31 |
2019-08-27 |
Celsee Diagnostics, Inc. |
System and method for isolating and analyzing cells
|
|
US9856535B2
(en)
|
2013-05-31 |
2018-01-02 |
Denovo Sciences, Inc. |
System for isolating cells
|
|
CN103333963A
(zh)
*
|
2013-06-09 |
2013-10-02 |
中国人民解放军第四军医大学 |
Egfr突变检测引物组及其用途
|
|
WO2014203918A1
(ja)
*
|
2013-06-19 |
2014-12-24 |
学校法人 久留米大学 |
上皮成長因子受容体チロシンキナーゼ阻害薬の治療効果を予測する方法
|
|
CA2917667A1
(en)
|
2013-07-09 |
2015-01-15 |
Dana-Farber Cancer Institute, Inc. |
Kinase inhibitors for the treatment of disease
|
|
EP3087394A2
(en)
|
2013-12-27 |
2016-11-02 |
Merrimack Pharmaceuticals, Inc. |
Biomarker profiles for predicting outcomes of cancer therapy with erbb3 inhibitors and/or chemotherapies
|
|
US9242965B2
(en)
|
2013-12-31 |
2016-01-26 |
Boehringer Ingelheim International Gmbh |
Process for the manufacture of (E)-4-N,N-dialkylamino crotonic acid in HX salt form and use thereof for synthesis of EGFR tyrosine kinase inhibitors
|
|
CN103923975B
(zh)
*
|
2014-01-27 |
2016-01-20 |
上海涌泰生物医药科技有限公司 |
一种检测egfr基因外显子19缺失突变的试剂盒和方法
|
|
WO2015178946A1
(en)
|
2014-04-04 |
2015-11-26 |
Biodesix, Inc. |
Treatment selection for lung cancer patients using mass spectrum of blood-based sample
|
|
BR112017001474A2
(pt)
*
|
2014-07-28 |
2018-02-20 |
Bardelli Alberto |
mutações no domínio extracelular iii do gene receptor de fator de crescimento epidérmico
|
|
WO2016055380A1
(en)
|
2014-10-09 |
2016-04-14 |
Roche Diagnostics Gmbh |
Mutations in the epidermal growth factor receptor kinase domain
|
|
KR101692044B1
(ko)
*
|
2014-12-05 |
2017-01-04 |
사회복지법인 삼성생명공익재단 |
교모세포종에서 표피 성장인자 수용체 억제제의 치료 효과를 예측하는 방법
|
|
US20160333087A1
(en)
*
|
2015-05-12 |
2016-11-17 |
Bioven 3 Limited |
Methods and compositions for inhibition of egf/egfr pathway in combination with tyrosine kinase inhibitors
|
|
US10184006B2
(en)
|
2015-06-04 |
2019-01-22 |
Merrimack Pharmaceuticals, Inc. |
Biomarkers for predicting outcomes of cancer therapy with ErbB3 inhibitors
|
|
PE20181300A1
(es)
|
2015-11-02 |
2018-08-09 |
Five Prime Therapeutics Inc |
Polipeptidos del dominio extracelular de cd80 y su uso en el tratamiento del cancer
|
|
KR20180091119A
(ko)
*
|
2016-02-12 |
2018-08-14 |
난토믹스, 엘엘씨 |
암 면역요법을 위한 치료 표적으로 환자 특이적 네오에피토프의 높은 스루풋 식별 (high-throughput identification of patient-specific neoepitopes as therapeutic targets for cancer immunotherapies)
|
|
CN105624309B
(zh)
*
|
2016-02-23 |
2020-04-21 |
深圳华大生命科学研究院 |
检测EGFR和/或K-ras基因突变的引物、探针及试剂盒
|
|
CN105866217B
(zh)
*
|
2016-03-21 |
2018-04-10 |
杭州市红十字会医院 |
三尖杉酯碱癌症治疗效果检测装置及方法
|
|
CN109983135A
(zh)
*
|
2016-05-25 |
2019-07-05 |
建喾立嗣股份公司 |
表皮细胞生长因子受体基因突变检测用组合物及包含其的试剂盒
|
|
KR20240059648A
(ko)
|
2017-04-19 |
2024-05-07 |
더 보드 오브 리젠츠 오브 더 유니버시티 오브 텍사스 시스템 |
조작된 항원 수용체를 발현하는 면역 세포
|
|
CN109937603B
(zh)
*
|
2017-05-03 |
2021-12-28 |
华为技术有限公司 |
基于竞争的传输方法和设备
|
|
US10299039B2
(en)
|
2017-06-02 |
2019-05-21 |
Apple Inc. |
Audio adaptation to room
|
|
WO2019046307A1
(en)
|
2017-08-29 |
2019-03-07 |
Celsee Diagnostics, Inc. |
SYSTEM AND METHOD FOR ISOLATING AND ANALYZING CELLS
|
|
WO2019074920A1
(en)
*
|
2017-10-10 |
2019-04-18 |
Oncocyte Corporation |
METHODS AND COMPOSITIONS FOR THE DETECTION AND DIAGNOSIS OF BREAST CANCER
|
|
CN109722476A
(zh)
*
|
2017-10-31 |
2019-05-07 |
北京雅康博生物科技有限公司 |
用于检测egfr基因2237-2257位突变的引物、探针及试剂盒
|
|
CN111918661A
(zh)
|
2018-02-21 |
2020-11-10 |
得克萨斯大学体系董事会 |
用于活化和扩增自然杀伤细胞的方法及其用途
|
|
CA3099106A1
(en)
*
|
2018-05-01 |
2019-11-07 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
T cell receptors which recognize mutated egfr
|
|
WO2020080871A2
(ko)
*
|
2018-10-18 |
2020-04-23 |
(주)신테카바이오 |
암 약물 반응성 판단을 위한 바이오 마커 조성물, 바이오 마커 조성물을 이용한 암 약물 반응성 판단 방법 및 암 약물 반응성 판단을 위한 바이오 마커 조성물 검출용 진단칩
|
|
WO2020174370A2
(en)
|
2019-02-26 |
2020-09-03 |
Janssen Biotech, Inc. |
Combination therapies and patient stratification with bispecific anti-egfr/c-met antibodies
|
|
US10633693B1
(en)
|
2019-04-16 |
2020-04-28 |
Celsee Diagnostics, Inc. |
System and method for leakage control in a particle capture system
|
|
US11578322B2
(en)
|
2019-05-07 |
2023-02-14 |
Bio-Rad Laboratories, Inc. |
System and method for automated single cell processing
|
|
US11273439B2
(en)
|
2019-05-07 |
2022-03-15 |
Bio-Rad Laboratories, Inc. |
System and method for target material retrieval from microwells
|
|
US11879013B2
(en)
|
2019-05-14 |
2024-01-23 |
Janssen Biotech, Inc. |
Combination therapies with bispecific anti-EGFR/c-Met antibodies and third generation EGFR tyrosine kinase inhibitors
|
|
AU2020290981B2
(en)
|
2019-06-14 |
2024-03-07 |
Bio-Rad Laboratories, Inc. |
System and method for automated single cell processing and analyses
|
|
GB2627085B
(en)
|
2019-11-06 |
2024-11-13 |
Univ Leland Stanford Junior |
Methods and systems for analysing nucleic acid molecules
|
|
JOP20220184A1
(ar)
|
2020-02-12 |
2023-01-30 |
Janssen Biotech Inc |
علاج مصابي السرطان ممن لديهم طفرات تخطي c-Met إكسون14
|
|
US11211144B2
(en)
|
2020-02-18 |
2021-12-28 |
Tempus Labs, Inc. |
Methods and systems for refining copy number variation in a liquid biopsy assay
|
|
US11475981B2
(en)
|
2020-02-18 |
2022-10-18 |
Tempus Labs, Inc. |
Methods and systems for dynamic variant thresholding in a liquid biopsy assay
|
|
US11211147B2
(en)
|
2020-02-18 |
2021-12-28 |
Tempus Labs, Inc. |
Estimation of circulating tumor fraction using off-target reads of targeted-panel sequencing
|
|
CN111154881A
(zh)
*
|
2020-03-09 |
2020-05-15 |
南京实践医学检验有限公司 |
一种急性髓系白血病中基因突变的检测试剂盒及应用
|
|
US11504719B2
(en)
|
2020-03-12 |
2022-11-22 |
Bio-Rad Laboratories, Inc. |
System and method for receiving and delivering a fluid for sample processing
|
|
US20220025453A1
(en)
*
|
2020-07-23 |
2022-01-27 |
Michael Y Sha |
Xenonucleic acid-mediated multiplex qpcr clamping technology for lung cancer mutation detection
|
|
CN114107449B
(zh)
*
|
2020-08-31 |
2024-04-09 |
中山大学孙逸仙纪念医院 |
一种单细胞内原位qPCR方法
|
|
CN111996193B
(zh)
*
|
2020-09-11 |
2024-02-20 |
北京键凯科技股份有限公司 |
一种有效抑制表皮生长因子受体表达的siRNA序列
|
|
US11783912B2
(en)
|
2021-05-05 |
2023-10-10 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods and systems for analyzing nucleic acid molecules
|
|
CN113564255A
(zh)
*
|
2021-08-13 |
2021-10-29 |
河北医科大学第四医院 |
一种lncRNA NEAT1_1的应用
|
|
DE102021126650A1
(de)
|
2021-10-14 |
2023-04-20 |
Rheinische Friedrich-Wilhelms-Universität Bonn, Körperschaft des öffentlichen Rechts |
Verfahren zur bestimmung der ansprechwahrscheinlichkeit einer malignen erkrankung auf eine behandlung mit einem pharmazeutischen hemmwirkstoff
|
|
EP4444910A4
(en)
|
2021-12-10 |
2025-11-05 |
Bio Rad Laboratories Inc |
Compositions, processes and systems for the treatment of samples with functionalized particles of adjustable morphology
|
|
CN114113265B
(zh)
*
|
2021-12-14 |
2023-08-08 |
郑州轻工业大学 |
一种适配体传感器及其制备方法
|
|
CN119053329A
(zh)
*
|
2022-03-31 |
2024-11-29 |
日商科迪亚制药股份有限公司 |
利用咪唑并[4,5-b]吡啶衍生物治疗实体瘤的生物标志物
|
|
TW202515577A
(zh)
*
|
2023-06-27 |
2025-04-16 |
日商大鵬藥品工業股份有限公司 |
患有具有ｅｇｆｒ畸變的非小細胞肺癌之個體的治療方法
|
|
WO2025018697A1
(ko)
*
|
2023-07-14 |
2025-01-23 |
전남대학교산학협력단 |
암 진단을 위한 시료 처리 방법 및 이를 이용한 암 진단에 대한 정보 제공 방법
|
|
CN117778322B
(zh)
*
|
2023-12-17 |
2025-02-07 |
苏州拓维生物技术有限公司 |
一种对恩杂鲁胺耐药的细胞系的筛选方法及其应用
|